B cell depletion in autoimmune rheumatic diseases

被引:21
|
作者
Pitashny, M
Shoenfeld, Y
机构
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Incumbent Laura Schwarz Kipp Chair Res Autoimmune, IL-69978 Tel Aviv, Israel
关键词
anti-CD20; rituximab; autoimmune diseases; B cell depletion;
D O I
10.1016/j.autrev.2005.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rituximab is a chimeric mouse-human monoclonal antibody, which binds to CD20, a B cell surface marker, leading to cell death by complement induced lysis and apoptosis. Since the introduction of this drug in the treatment of non-Hodgkin lymphoma, its applications have been extended to autoimmune diseases. This review summarizes the actual possible uses of this novel immune system targeted drug, and explains the mechanism of B cell depletion in autoimmune diseases. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:436 / 441
页数:6
相关论文
共 50 条
  • [1] B cell checkpoints in autoimmune rheumatic diseases
    Rubin, Samuel J. S.
    Bloom, Michelle S.
    Robinson, William H.
    NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (05) : 303 - 315
  • [2] B cell checkpoints in autoimmune rheumatic diseases
    Samuel J. S. Rubin
    Michelle S. Bloom
    William H. Robinson
    Nature Reviews Rheumatology, 2019, 15 : 303 - 315
  • [3] B cell depletion therapy in autoimmune diseases
    Sanz, Inaki
    Anolik, Jennifer H.
    Looney, R. John
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2546 - 2567
  • [4] B-cell depletion in autoimmune diseases
    Schett, Georg
    Nagy, Gyoergy
    Kroenke, Gerhard
    Mielenz, Dirk
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11) : 1409 - 1420
  • [5] ALTERATIONS IN B CELL SUBSETS AND BAFF LEVELS IN AUTOIMMUNE RHEUMATIC DISEASES TREATED WITH B CELL DEPLETION THERAPY RITUXIMAB
    Lutalo, Pamela M. K.
    D'Cruz, David
    Spencer, Jo
    RHEUMATOLOGY, 2015, 54 : 163 - 163
  • [6] Alterations in B Cell Subsets and BAFF Levels in Autoimmune Rheumatic Diseases Treated with B Cell Depletion Therapy: Rituximab
    Lutalo, Pamela M. K.
    D'Cruz, David P.
    Spencer, Jo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1178 - S1179
  • [7] B cell depletion for autoimmune diseases in paediatric patients
    Jansson, Annette F.
    Sengler, Claudia
    Kuemmerle-Deschner, Jasmin
    Gruhn, Bernd
    Kranz, A. Birgitta
    Lehmann, Hartwig
    Kleinert, Daniela
    Pape, Lars
    Girschick, Hermann J.
    Foeldvari, Ivan
    Haffner, Dieter
    Haas, Johannes P.
    Moebius, Dagmar
    Foell, Dirk
    Peitz, Joachim
    Grote, Veit
    CLINICAL RHEUMATOLOGY, 2011, 30 (01) : 87 - 97
  • [8] B-Cell depletion and repopulation in autoimmune diseases
    Pers, Jacques-Olivier
    Daridon, Capucine
    Bendaoud, Boutahar
    Devauchelle, Valerie
    Berthou, Christian
    Saraux, Alain
    Youinou, Pierre
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (01) : 50 - 55
  • [9] B-Cell Depletion and Repopulation in Autoimmune Diseases
    Jacques-Olivier Pers
    Capucine Daridon
    Boutahar Bendaoud
    Valérie Devauchelle
    Christian Berthou
    Alain Saraux
    Pierre Youinou
    Clinical Reviews in Allergy & Immunology, 2008, 34 : 50 - 55
  • [10] B cell depletion for autoimmune diseases in paediatric patients
    Annette F. Jansson
    Claudia Sengler
    Jasmin Kuemmerle-Deschner
    Bernd Gruhn
    A. Birgitta Kranz
    Hartwig Lehmann
    Daniela Kleinert
    Lars Pape
    Hermann J. Girschick
    Ivan Foeldvari
    Dieter Haffner
    Johannes P. Haas
    Dagmar Moebius
    Dirk Foell
    Joachim Peitz
    Veit Grote
    Clinical Rheumatology, 2011, 30 : 87 - 97